{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:26:06Z","timestamp":1784204766476,"version":"3.55.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop and validate a novel model for predicting biochemical recurrence (BCR) in elderly prostate cancer (PCa) patients after radical prostatectomy (RP) and to create an accessible online tool for its clinical application.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included patients who underwent RP at two independent medical centers. The initial cohort included 450 patients (2015-2022), which were randomly divided into a training set (n = 315) and an internal validation set (n = 135) at a 7:3 ratio. An independent cohort of 175 patients (2013-2023) was used as the external validation set. Potential predictors were screened via univariable Cox regression. The independent prognostic factors for BCR were subsequently identified via multivariate Cox regression. A predictive nomogram was developed on the basis of these independent factors. The model performance was assessed via time-dependent ROC curves, calibration curves, decision curve analysis (DCA), and Kaplan\u2013Meier (KM) curves.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Cox multivariate regression analysis revealed that Gleason score (GS), lymph node metastasis (LNM), seminal vesicle invasion (SVI), and free prostate-specific antigen (fPSA) were independent risk factors for BCR after RP in the elderly population (all\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05). The nomogram exhibited excellent time-dependent discriminative ability: the AUCs for 2-year, 3-year, and 5-year BCR-free survival were 0.857, 0.915, and 0.916, respectively, in the training set; 0.810, 0.846, and 0.856, respectively, in the internal validation set; and 0.698, 0.679, and 0.715, respectively, in the external validation set. Calibration curves demonstrated good agreement between the predicted BCR risk and actual incidence, and DCA confirmed that the model provides substantial clinical net benefit. We further developed an online tool (\n                      <jats:ext-link>https:\/\/bcrnomapp.shinyapps.io\/bcr-risk\/<\/jats:ext-link>\n                      ) for personalized BCR-risk prediction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We developed a validated nomogram based on four independent risk factors\u2014the Gleason score, lymph node metastasis, seminal vesicle invasion, and free PSA\u2014for predicting BCR in elderly prostate cancer patients after radical prostatectomy. This model demonstrated robust predictive performance across multiple validation sets. The accompanying web-based tool facilitates rapid and individualized risk assessment, aiding in clinical decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1753318","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T05:23:19Z","timestamp":1773638599000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of an online predictive model for biochemical recurrence after radical prostatectomy in elderly patients"],"prefix":"10.3389","volume":"16","author":[{"given":"Jie","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"College of Artificial Intelligence Medicine, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangxin","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglin","family":"Wu","sequence":"additional","affiliation":[{"name":"Chongqing Cancer Multi-omics Big Data Application Engineering Research Center, Chongqing University Cancer Hospital","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Public Health, Chongqing Medical University","place":["Chongqing, China"]},{"name":"Research Center for Medical and Social Development, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhao","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"College of Artificial Intelligence Medicine, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70028","article-title":"Prostate cancer statistics, 2025","volume":"75","author":"Tyler","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Freddie","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0254-9026.2025.02.001","article-title":"Chinese expert consensus on the diagnosis and management of prostate cancer in the elderly(2024 edition)","volume":"44","author":"Pang","year":"2025","journal-title":"Chin J Geriatr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.11.013","article-title":"Recent patterns and trends in global prostate cancer incidence and mortality: an update","volume":"87","author":"Elizabeth","year":"2024","journal-title":"Eur Urol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/bju.16482","article-title":"Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics","volume":"134","author":"Roberts","year":"2024","journal-title":"Bju Int"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-023-00712-z","article-title":"Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification","volume":"27","author":"Neal","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17081272","article-title":"Diagnostic capability and improved clinical management of 18f-dcfpyl-psma pet\/ct in occult biochemical recurrence of prostate cancer after prostatectomy","volume":"17","author":"Francesco","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01677-3","article-title":"Micrornas as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data","volume":"126","author":"Sharmila","year":"2022","journal-title":"Br J Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.10.011","article-title":"Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review","volume":"75","author":"Van den Broeck","year":"2018","journal-title":"Eur Urol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.10.766","article-title":"A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer","volume":"90","author":"Kattan","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26169","article-title":"The capra-s score: a straightforward tool for improved prediction of outcomes after radical prostatectomy","volume":"117","author":"Matthew","year":"2011","journal-title":"Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93860-y","article-title":"Prediction of a positive surgical margin and biochemical recurrence after robot-assisted radical prostatectomy","volume":"11","author":"Ching-Wei","year":"2021","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/iju.12624","article-title":"Prediction of biochemical recurrence after robot-assisted radical prostatectomy: analysis of 784 Japanese patients","volume":"22","author":"Takeshi","year":"2014","journal-title":"Int J Urol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000002222","article-title":"A nomogram for predicting lymph node metastases in nonmetastatic muscle-invasive bladder cancer: a seer-based investigation","volume":"111","author":"Jie","year":"2025","journal-title":"Int J Surg"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12922-2","article-title":"Prognostic factors and prognostic model of non-metastatic clear cell renal cell carcinoma","volume":"24","author":"Juanyan","year":"2024","journal-title":"BMC Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2020.1795694","article-title":"Preoperative nutritional risk index predicts recurrence of oligometastatic prostate cancer in patients undergoing cytoreductive radical prostatectomy","volume":"73","author":"Yadong","year":"2020","journal-title":"Nutr Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.893877","article-title":"The values of systemic immune-inflammation index and neutrophil-lymphocyte ratio in predicting testicular germ cell tumors: a retrospective clinical study","volume":"12","author":"Shuo","year":"2022","journal-title":"Front Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.223349","article-title":"Multiparametric mri-based 5-year risk prediction model for biochemical recurrence of prostate cancer after radical prostatectomy","volume":"309","author":"Stefano","year":"2023","journal-title":"Radiology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133416","article-title":"Novel multiparametric magnetic resonance imaging-based deep learning and clinical parameter integration for the prediction of long-term biochemical recurrence-free survival in prostate cancer after radical prostatectomy","volume":"15","author":"Hye Won","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.07.004","article-title":"Prognostic factors for biochemical recurrence more than 10 years after radical prostatectomy","volume":"197","author":"Lea","year":"2016","journal-title":"J Urol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.3163","article-title":"Predictors of time to biochemical recurrence in a radical prostatectomy cohort within the psa-era","volume":"10","author":"Ahva","year":"2016","journal-title":"Can Urol Assoc J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-019-01445-7","article-title":"Predictive factors for short-term biochemical recurrence-free survival after robot-assisted laparoscopic radical prostatectomy in high-risk prostate cancer patients","volume":"24","author":"Mitsugu","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-017-2502-7","article-title":"Impact of gleason score on biochemical recurrence in patients with pt3an0\/nx prostate cancer with positive surgical margins: a multicenter study from the prostate cancer research committee","volume":"143","author":"Wan","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2020.10.016","article-title":"Management of lymph node metastasis via local chemotherapy can prevent distant metastasis and improve survival in mice","volume":"329","author":"Heegon","year":"2020","journal-title":"J Control Release"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5153-z","article-title":"Perineural invasion and lymphovascular invasion are associated with increased risk of biochemical recurrence in patients undergoing radical prostatectomy","volume":"23","author":"Minyong","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-14691-x","article-title":"Prognostic importance of lymphovascular invasion for specific subgroup of patients with prostate cancer after robot-assisted radical prostatectomy (the msug94 group)","volume":"31","author":"Makoto","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58081057","article-title":"Bilateral seminal vesicle invasion is not associated with worse outcomes in locally advanced prostate carcinoma","volume":"58","author":"Natalia","year":"2022","journal-title":"Med (Kaunas)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2023.1264","article-title":"Bilateral seminal vesicle invasion as a strong prognostic indicator in t3b prostate cancer patients following radical prostatectomy: a comprehensive, multicenter, long-term follow-up study","volume":"56","author":"Jungyo","year":"2024","journal-title":"Cancer Res Treat"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017931","article-title":"Stratification based on adverse laboratory\/pathological features for predicting overall survival in patients undergoing radical prostatectomy: a k-cap registry-based analysis","volume":"98","author":"Jee Soo","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14505-1","article-title":"The research progress on diagnostic indicators related to prostate-specific antigen gray-zone prostate cancer","volume":"25","author":"Yeasin","year":"2025","journal-title":"BMC Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.998447","article-title":"Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer","volume":"13","author":"Jinhua","year":"2023","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.02.083","article-title":"Biology of prostate-specific antigen","volume":"21","author":"Balk","year":"2003","journal-title":"J Clin Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4103\/1008-682X.172823","article-title":"Performance of the prostate health index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonography","volume":"18","author":"Guo-Peng","year":"2016","journal-title":"Asian J Androl"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071324","article-title":"Blood-based dna methylation analysis by multiplexed obbpa-ddpcr to verify indications for prostate biopsies in suspected prostate cancer patients","volume":"16","author":"Markus","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15236","article-title":"Can post-treatment free psa ratio be used to predict adverse outcomes in recurrent prostate cancer","volume":"127","author":"Hanan","year":"2020","journal-title":"Bju Int"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21474","article-title":"Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hk2) and free prostate specific antigen (psa) in men with moderate psa-elevation in serum","volume":"118","author":"Thomas","year":"2005","journal-title":"Int J Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1753318\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T05:23:21Z","timestamp":1773638601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1753318\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":36,"alternative-id":["10.3389\/fonc.2026.1753318"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1753318","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"article-number":"1753318"}}